Free Newsletter
Online tool aid patient access to experimental drugs
In an effort to help doctors navigate the regulatory maze required to get investigational treatments for patients--as opposed to getting them for research purposes--the American Society of Clinical Oncology and the FDA have developed three educational modules. The course walks physicians through the process of gaining access to the drugs, providing a process overview, help in completing the application, and responsibilities concerning informed consent. The modules are free, and include links to templates for use in the process. Article | Modules
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: